Cabaletta Bio's market cap is currently $113.88M. The company's EPS TTM is $-2.155; its P/E ratio is ―; Cabaletta Bio is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -1.43M	$ -3.68M	$ -733.00K	$ -354.00K	$ -104.00K
Operating Income	$ -74.66M	$ -54.14M	$ -46.31M	$ -33.83M	$ -18.68M
EBITDA	$ -73.23M	$ -52.96M	$ -45.58M	$ -33.48M	$ -18.68M
Net Income	$ -67.67M	$ -51.81M	$ -45.53M	$ -32.49M	$ -15.10M
Balance Sheet
Cash & Short-Term Investments	$ 241.25M	$ 106.55M	$ 122.22M	$ 108.66M	$ 136.20M
Total Assets	$ 253.65M	$ 116.97M	$ 126.34M	$ 114.72M	$ 141.47M
Total Debt	$ 5.02M	$ 5.14M	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -188.22M	$ -76.47M	$ -122.22M	$ -101.43M	$ -136.20M
Total Liabilities	$ 17.45M	$ 12.45M	$ 8.38M	$ 5.18M	$ 3.15M
Stockholders' Equity	$ 236.20M	$ 104.52M	$ 117.96M	$ 109.54M	$ 138.32M
Cash Flow
Free Cash Flow	$ -54.24M	$ -48.83M	$ -35.27M	$ -27.41M	$ -16.74M
Operating Cash Flow	$ -53.55M	$ -46.38M	$ -34.11M	$ -26.77M	$ -16.05M
Investing Cash Flow	$ -22.45M	$ -27.22M	$ 6.00M	$ -7.98M	$ -693.00K
Financing Cash Flow	$ 187.63M	$ 32.98M	$ 48.90M	$ -24.00K	$ 119.92M

Currency in USD

Cabaletta Bio Earnings and Revenue History

Income Statement >

Cabaletta Bio Debt to Assets

Balance Sheet >

Cabaletta Bio Cash Flow

Cash Flow >

Cabaletta Bio Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing